Aarey Drugs & Pharmaceuticals Q2 Results
- BSE: 524412
- NSE: AAREYDRUGS
- ISIN: INE198H01019
- Sector: Biotechnology & Drugs
BSE
55.18
-2.05 (-3.58%)
-2.05 (-3.58%)Volume5.54 K
Updated: Mon 25 Nov, 2024 | 15:49:55
NSE
56.47
0.18 (0.32%)
0.18 (0.32%)Volume8.60 K
Updated: Mon 25 Nov, 2024 | 15:23:50
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹105.14 Cr.(-17.15%)
- Operating Profit₹3.23 Cr.(353.90%)
- Profit After Tax₹1.60 Cr.(28.86%)
- Operating Margin3.08%(23.71%)
Note: Comparison is on YoY basis
Quarterly - Aarey Drugs & Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 105.14 | 50.96 | -% | 57.83 | -% |
| Selling/ General/ Admin Expenses Total | 1.40 | 0.96 | -% | 0.41 | -% |
| Depreciation/ Amortization | 0.49 | 0.42 | -% | 0.41 | -% |
| Other Operating Expenses Total | 1.12 | 0.65 | -% | 0.41 | -% |
| Total Operating Expense | 101.91 | 50.03 | -% | 56.39 | -% |
| Operating Income | 3.23 | 0.92 | -% | 1.44 | -% |
| Net Income Before Taxes | 1.75 | 0.72 | -% | 1.01 | -% |
| Net Income | 1.60 | 0.72 | -% | 1.23 | -% |
| Diluted Normalized EPS | 0.57 | 0.29 | -% | 0.48 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST - Markets
02C2C Advanced Systems IPO Day 2: Check GMP, subscription status and other key details
2 min read06:59 PM IST - Markets
03Stocks to buy or sell: Dharmesh Shah of ICICI Securities recommends buying L&T, Syngene International on November 25
5 min read10:00 AM IST